Management of Insulinomas: Perioperative and Long-term Outcomes Following Enucleations and Pancreatic Resections in 198 Patients Abstract #249

Introduction: Enucleation represents the procedure of choice for the treatment of insulinomas. Considering the site and the number of lesions, however, formal pancreatic resection may be necessary.
Aim(s): To analyze perioperative and long-term outcomes after enucleation/pancreatic resections for insulinomas at two referral centers between 1990-2008.
Materials and methods: One-hundred and ninety-eight patients (116 females, median age 47.5 years) with symptomatic insulinoma were identified. 5.5% had MEN-1 syndrome. Surgical procedures included 106 enucleations (53.5%) and 92 pancreatic resections. There were no blind resections. Median FU was 65 months. Insulinomas were classified according to the 2000 and 2010 WHO PETs classifications.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr Stefano Crippa

To read results and conclusion, please login ...

Further abstracts you may be interested in

#339 Focal Nesidioblastosis in an Adult
Introduction: Nesidioblastosis is an uncommon cause of persistent hyperinsulinemic hypoglycemia (PHH) in adults. Although it is well-described in infants, the pathophysiology in adults is poorly understood.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Prof.Dr. Zafer N Canturk
Authors: Simsek T, Utkan Z, Canturk Z, Canturk Z, ...
#1482 Duodenum Preserving Pancreatic Head Resection for Neuroendocrine Pancreatic Tumors of the Head of the Pancreas.
Introduction: Duodenum Preserving Pancreatic Head Resection (DPPHR) is a surgical procedure uncommonly used in benign tumors of the head of the pancreas as alternative to pancreaticoduodenectomy.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Surgical treatment
Presenting Author: Doctor Valbona Liço
Keywords: dpphr
#2685 Apatinib Inhibits Tumor Growth and Angiogenesis in PNET Models
Introduction: Angiogenesis has a pivotal role in the growth and metastasis of pancreatic neuroendocrine tumors (PNETs). Apatinib inhibits angiogenesis as a highly selective KDR inhibitor and has been used to treat advanced gastric cancer and malignancies in clinical settings. However, the efficacy of apatinib in PNETs remains unclear.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Basic Science - In vitro models, tumor growth, CTCs
Presenting Author: Shan Wu
Authors: Wu S, Zhou J, Guo J, Hua Z, ...
#2737 Identification of a Novel MAFA Missense Mutation Causing Familial Insulinomatosis
Introduction: Insulinomatosis is a rare pancreatic disease characterized by an adult-onset condition of recurrent hyperinsulinemic hypoglycemia caused by multiple insulin-secreting neuroendocrine tumors.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: PD. Dr. Christian Fottner
#2761 Diagnosis and Management of Insulinomas. The Use of Current Practices in Pakistan
Introduction: Insulinomas are rare functional and benign neuroendocrine tumors of Pancreas.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - Targeted therapies
Presenting Author: Dr Arooj Fatima
Authors: Fatima A, Zaidi S S A, ...